Merck (MRK) Posts Q2 EPS of $0.86, Tops by 3c; Guides FY10 EPS
MRK Hot Sheet
Revenue Growth %: +1.3%Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
TARO, BRLI, TLB, More
Merck (NYSE: MRK) reports Q2 EPS of $0.86, 3 cents better than the analyst estimate of $0.83. Revenue for the quarter was $11.30 billion, which compares to the estimate of $11.45 billion.
Sees FY10 EPS of $3.29 - $3.39, compared to the consensus of $3.37.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Sees FY10 EPS of $3.29 - $3.39, compared to the consensus of $3.37.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
Create E-mail Alert Related Categories
Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
